Stepan Company Q4 2025 Earnings Call Summary

Strategic Performance and Operational Context - The company delivered 6% adjusted EBITDA growth in 2025 despite unprecedented raw material inflation, tariff impacts, and a challenging chemical sector macro environment [5] - Performance was driven by disciplined pricing and a favorable mix in crop productivity, oilfield, and specialty products, which offset softer demand in global consumer surfactants [5] - The Pasadena alkoxylation facility was successfully commissioned, marking a transition from a heavy investment phase to an operational ramp-up period [5] Financial Performance and Projections - Surfactant margins faced significant second-half pressure due to a lag in passing through elevated oleochemical costs, particularly the spike in coconut oil prices [5] - Polymers growth of 11% was supported by strong volume in North American and Asian rigid polyols, despite competitive pricing pressures from lower raw material pass-throughs [5] - Management prioritized balance sheet health, reducing the net leverage ratio from 2.8x to 2.5x through disciplined working capital management and positive free cash flow generation [5] Project Catalyst and Future Outlook - Project Catalyst aims to deliver $100 million in pretax savings over two years, with $60 million expected in 2026 to offset persistent 3% plus inflation in fixed costs [5] - The Pasadena facility is projected to reach 70% to 80% utilization in 2026, achieving full utilization by 2027 as volume shifts from less efficient sites [5] - Management expects a back-half weighted 2026 performance as oleochemical cost relief and structural savings from footprint optimization materialize in the second half [5] Capital Expenditure and Strategic Changes - Capital expenditure is guided to a lower range of $105 million to $115 million for 2026, reflecting a shift toward sustaining capital and targeted growth projects post-Pasadena [5] - The company announced the closure of the Fieldsboro, New Jersey site and decommissioning of select assets at Millsdale and Stalybridge to address declining commodity surfactant demand [5] - The company is exiting a low-margin, high-capital organics business in the U.K. to improve overall Return on Invested Capital (ROIC) [5] Dividend and Shareholder Commitment - The 58th consecutive annual dividend increase underscores management's commitment to shareholder returns despite the current restructuring phase [6]